The Journal of
Clinical Psychiatry

Volume 66 • 2005 • 12

Publisher's Note

2005-A Year of Accomplishments

J Clin Psychiatry 2005;66(12):1506-1506

Editorial

Another Year Passes

J Clin Psychiatry 2005;66(12):1507-1511

Alan J. Gelenberg, MD

Original Research

Dosing of Quetiapine in Schizophrenia: How Clinical Practice Differs From Registration Studies

J Clin Psychiatry 2005;66(12):1512-1516

Leslie Citrome, MD, MPH ; Ari Jaffe, MD ; Jerome Levine, MD ; Jean-Pierre Lindenmayer, MD

Original Research

Clinical Predictors of Drug Nonresponse in Obsessive-Compulsive Disorder

J Clin Psychiatry 2005;66(12):1517-1523

Chandrashekhar N. Shetti, DPM, MD ; Y. C. Janardhan Reddy, DPM, MD ; Thennarasu Kandavel, PhD ; Kartik Kashyap, DPM ; Srinivas Singisetti, MD ; Avinash S. Hiremath, MD ; Mulia Umar-Faruq Siddequehusen, MD ; Samar Raghunandanan, MD

Original Research

Long-Term Maintenance Therapy for Major Depressive Disorder With rTMS.

J Clin Psychiatry 2005;66(12):1524-1528

John P. O'Reardon, MD ; Kate H. Blumner, MPH ; Andrew D. Peshek, D ; Rocio Romero Pradilla, MD ; Pilar Cristancho Pimiento, MD

Original Research

Antidepressant Treatment Outcomes of Psychogenic Movement Disorder

J Clin Psychiatry 2005;66(12):1529-1534

Valerie Voon, MD ; Anthony E. Lang, MD

Original Research

Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression: Acute Response and Long-Term Remission Rates.

J Clin Psychiatry 2005;66(12):1535-1540

Francesco Benedetti, MD ; Barbara Barbini, MD ; Mara Cigala Fulgosi, MD ; Cristina Colombo, MD ; Sara Dallaspezia, MD ; Adriana Pontiggia, MD ; Enrico Smeraldi, MD

Original Research

Baseline Predictors of Response to Divalproex in Conduct Disorder

J Clin Psychiatry 2005;66(12):1541-1548

Kirti Saxena, MD ; Melissa A. Silverman, BA ; Kiki Chang, MD ; Leena Khanzode, MD ; Hans Steiner, MD

Original Research

Defining Response in Clinical Trials for Obsessive-Compulsive Disorder: A Signal Detection Analysis of the Yale-Brown Obsessive Compulsive Scale

J Clin Psychiatry 2005;66(12):1549-1557

David F. Tolin, PhD ; Jonathan S. Abramowitz, PhD ; Gretchen J. Diefenbach, PhD

Original Research

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

J Clin Psychiatry 2005;66(12):1558-1563

Vladimir Lerner, MD, PhD ; Chanoch Miodownik, MD ; Alexander Kaptsan, MD ; Tali Vishne, MD ; Ben-Ami Sela, PhD ; Joseph Levine, MD

Original Research

Olanzapine Versus Risperidone in Newly Admitted Acutely Ill Psychotic Patients

J Clin Psychiatry 2005;66(12):1564-1568

John E. Kraus, MD. PhD ; Brian B. Sheitman, MD ; Alan Cook, MD ; Robert Reviere, PhD ; Jeffrey A. Lieberman, MD

Original Research

Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial

J Clin Psychiatry 2005;66(12):1569-1575

David Rossini, MD ; Lorenzo Magri, MD ; Adelio Lucca, MD ; Silvia Giordani, MD ; Enrico Smeraldi, MD ; Raffaella Zanardi, MD

Original Research

Wellness Intervention for Patients With Serious and Persistent Mental Illness

J Clin Psychiatry 2005;66(12):1576-1579

Vicki Poole Hoffmann, PharmD ; Jonna Ahl, PhD ; Adam Meyers, MS ; Leslie Schuh, PhD ; Kenneth S. Shults, BS ; Dorothy M. Collins, BA ; Lara Jensen, MBA

Original Research

Peer-to-Peer Psychoeducation in Schizophrenia: A New Approach

J Clin Psychiatry 2005;66(12):1580-1585

Christine B. Rummel, MD ; Wulf-Peter Hansen ; Alexandra Helbig ; Gabriele Pitschel-Walz, PhD ; Werner Kissling, MD

Original Research

A Retrospective Analysis of Risk and Protective Factors for Natural Death in Bipolar Disorder

J Clin Psychiatry 2005;66(12):1586-1591

Shang-Ying Tsai, MD ; Chao-Hsien Lee, PhD ; Chian-Jue Kuo, MD ; Chiao-Chicy Chen, MD, PhD

Original Research

Open-Label Risperidone for Asperger's Disorder: Negative Symptom Spectrum Response

J Clin Psychiatry 2005;66(12):1592-1597

Jeffrey L. Rausch, MD ; Elizabeth L. Sirota, MD ; Donna L. Londino, MD ; Maria E. Johnson, MD ; Benjamin M. Carr, MD ; Renu Bhatia, MD ; Stephen Miller, PhD

Academic Highlights

Focus on Bipolar Disorder Treatment.

J Clin Psychiatry 2005;66(12):1598-1609

Charles L. Bowden, MD ; Terence A. Ketter, MD ; Gary S. Sachs, MD ; Michael E. Thase, M.D.

ASCP Corner

Real-Life Dosing With Second-Generation Antipsychotics

J Clin Psychiatry 2005;66(12):1610-1611

Christoph U. Correll, MD

Letter to the Editor

Effects of the Traditional Chinese Herbal Medicine Yi-Gan San for Cholinesterase Inhibitor-Resistant Visual Hallucinations and Neuropsychiatric Symptoms in Patients With Dementia With Lewy Bodies

J Clin Psychiatry 2005;66(12):1612-1613

Koh Iwasaki, MD, PhD ; Masahiro Maruyama, MD, PhD ; Naoki Tomita, MD ; Katsutoshi Furukawa, MD, PhD ; Miyako Nemoto, MD ; Hironori Fujiwara, MD, PhD ; Takashi Seki, MD, PhD ; Masahiko Fujii, MD, PhD ; Manabu Kodama, MD, PhD ; Hiroyuki Arai, MD, PHD

Letter to the Editor

Omega-3 Fatty Acids Are More Beneficial in the Depressive Phase Than in the Manic Phase in Patients With Bipolar I Disorder."

J Clin Psychiatry 2005;66(12):1613-1614

Chih-Chiang Chiu, MD ; Shih-Yi Huang, PhD ; Chiao-Chicy Chen, PhD ; Kuan-Pin, MD

Letter to the Editor

Hypotension Secondary to the Combination of Intramuscular Olanzapine and Intramuscular Lorazepam

J Clin Psychiatry 2005;66(12):1614-1615

Jennifer L. Zacher, PharmD ; Jennifer Roche-Desilets, PharmD, BCPS

Letter to the Editor

Placebo Response in Psychotic Depression

J Clin Psychiatry 2005;66(12):1615-1615

Anthony J. Rothschild, MD

Letter to the Editor

Reply to "Placebo Response in Psychotic Depression"

J Clin Psychiatry 2005;66(12):1615-1616

George M. Simpson, MD ; Steven J. Kingsbury, MD, PhD

Letter to the Editor

Clonidine-Induced Gynecomastia and Hyperprolactinemia in a 6-Year-Old Child

J Clin Psychiatry 2005;66(12):1616-1616

Dattatreya N. Mendhekar, DPM, MD

Book Review

Clinical Handbook of Psychotropic Drugs for Children and Adolescents

J Clin Psychiatry 2005;66(12):1617-1617

Pieter Joost van Wattum, MD, MA

Book Review

Neuropsychiatric Assessment

J Clin Psychiatry 2005;66(12):1617-1618

Howard S. Kirshner, MD

Book Review

Manual of Psychiatric Care for the Medically Ill

J Clin Psychiatry 2005;66(12):1618-1618

Catherine Chiles, MD

Volume 66 • 2005 • 12

Publisher's Note

2005-A Year of Accomplishments

Editorial

Another Year Passes

Original Research

Dosing of Quetiapine in Schizophrenia: How Clinical Practice Differs From Registration Studies

Clinical Predictors of Drug Nonresponse in Obsessive-Compulsive Disorder

Long-Term Maintenance Therapy for Major Depressive Disorder With rTMS.

Antidepressant Treatment Outcomes of Psychogenic Movement Disorder

Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression: Acute Response and Long-Term Remission Rates.

Baseline Predictors of Response to Divalproex in Conduct Disorder

Defining Response in Clinical Trials for Obsessive-Compulsive Disorder: A Signal Detection Analysis of the Yale-Brown Obsessive Compulsive Scale

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

Olanzapine Versus Risperidone in Newly Admitted Acutely Ill Psychotic Patients

Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial

Wellness Intervention for Patients With Serious and Persistent Mental Illness

Peer-to-Peer Psychoeducation in Schizophrenia: A New Approach

A Retrospective Analysis of Risk and Protective Factors for Natural Death in Bipolar Disorder

Open-Label Risperidone for Asperger's Disorder: Negative Symptom Spectrum Response

Academic Highlights

Focus on Bipolar Disorder Treatment.

ASCP Corner

Real-Life Dosing With Second-Generation Antipsychotics

Letter to the Editor

Effects of the Traditional Chinese Herbal Medicine Yi-Gan San for Cholinesterase Inhibitor-Resistant Visual Hallucinations and Neuropsychiatric Symptoms in Patients With Dementia With Lewy Bodies

Omega-3 Fatty Acids Are More Beneficial in the Depressive Phase Than in the Manic Phase in Patients With Bipolar I Disorder."

Hypotension Secondary to the Combination of Intramuscular Olanzapine and Intramuscular Lorazepam

Placebo Response in Psychotic Depression

Reply to "Placebo Response in Psychotic Depression"

Clonidine-Induced Gynecomastia and Hyperprolactinemia in a 6-Year-Old Child

Book Review

Clinical Handbook of Psychotropic Drugs for Children and Adolescents

Neuropsychiatric Assessment

Manual of Psychiatric Care for the Medically Ill

ELSEWHERE:

FOLLOW US:

Volume 66 • 2005 • 12

Publisher's Note

2005-A Year of Accomplishments

Editorial

Another Year Passes

Original Research

Dosing of Quetiapine in Schizophrenia: How Clinical Practice Differs From Registration Studies

Clinical Predictors of Drug Nonresponse in Obsessive-Compulsive Disorder

Long-Term Maintenance Therapy for Major Depressive Disorder With rTMS.

Antidepressant Treatment Outcomes of Psychogenic Movement Disorder

Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression: Acute Response and Long-Term Remission Rates.

Baseline Predictors of Response to Divalproex in Conduct Disorder

Defining Response in Clinical Trials for Obsessive-Compulsive Disorder: A Signal Detection Analysis of the Yale-Brown Obsessive Compulsive Scale

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

Olanzapine Versus Risperidone in Newly Admitted Acutely Ill Psychotic Patients

Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial

Wellness Intervention for Patients With Serious and Persistent Mental Illness

Peer-to-Peer Psychoeducation in Schizophrenia: A New Approach

A Retrospective Analysis of Risk and Protective Factors for Natural Death in Bipolar Disorder

Open-Label Risperidone for Asperger's Disorder: Negative Symptom Spectrum Response

Academic Highlights

Focus on Bipolar Disorder Treatment.

ASCP Corner

Real-Life Dosing With Second-Generation Antipsychotics

Letter to the Editor

Effects of the Traditional Chinese Herbal Medicine Yi-Gan San for Cholinesterase Inhibitor-Resistant Visual Hallucinations and Neuropsychiatric Symptoms in Patients With Dementia With Lewy Bodies

Omega-3 Fatty Acids Are More Beneficial in the Depressive Phase Than in the Manic Phase in Patients With Bipolar I Disorder."

Hypotension Secondary to the Combination of Intramuscular Olanzapine and Intramuscular Lorazepam

Placebo Response in Psychotic Depression

Reply to "Placebo Response in Psychotic Depression"

Clonidine-Induced Gynecomastia and Hyperprolactinemia in a 6-Year-Old Child

Book Review

Clinical Handbook of Psychotropic Drugs for Children and Adolescents

Neuropsychiatric Assessment

Manual of Psychiatric Care for the Medically Ill

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles